BCM
GSK icon

BlueCrest Capital Management’s GSK GSK Stock Holding History

BlueCrest Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-169,170
Closed -$8.52M – 1619
2018
Q2 		$8.52M Buy
+169,170
New +$8.52M 0.22% 95
2017
Q2 		– Sell
-40,926
Closed -$2.16M – 984
2017
Q1 		$2.16M Buy
40,926
+30,526
+294% +$1.55M 0.1% 226
2016
Q4 		$501K Buy
+10,400
New +$514K 0.03% 467

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlueCrest Capital Management's GSK Position: Q3 2018 in Review

BlueCrest Capital Management sold out of GSK (GSK) in Q3 2018, closing a stake of 169,170 shares — an estimated $8.52M sold.

BlueCrest Capital Management first reported a position in GSK in Q4 2016 and held it in 3 quarters. The position peaked at $8.52M in Q2 2018. 787 funds tracked by Wall St. Rank hold GSK as of Q3 2018.

  • BlueCrest Capital Management reported no remaining GSK position as of Q3 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 169,170 GSK shares in Q3 2018, an estimated $8.52M.
  • BlueCrest Capital Management first reported a position in GSK in Q4 2016 and held it in 3 quarters.
  • BlueCrest Capital Management's GSK position peaked at $8.52M in Q2 2018.
  • 787 funds tracked by Wall St. Rank held GSK as of Q3 2018.

Based on BlueCrest Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.